Victory Capital Management Inc Meridian Bioscience Inc Transaction History

Victory Capital Management Inc

$95.8 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$31.15 - $33.39 $1,370 - $1,469	44 Added 0.17%	26,441 $878,000
Q4 2022 Feb 09, 2023	SELL	$31.15 - $33.39 $547,305 - $586,662	-17,570 Reduced 39.96%	26,397 $876,000
Q3 2022 Nov 02, 2022	SELL	$30.9 - $33.55 $3.36 Million - $3.65 Million	-108,816 Reduced 71.22%	43,967 $1.39 Million
Q2 2022 Aug 01, 2022	SELL	$23.75 - $31.69 $148,271 - $197,840	-6,243 Reduced 3.93%	152,783 $4.65 Million
Q1 2022 May 04, 2022	BUY	$19.97 - $26.94 $87,768 - $118,401	4,395 Added 2.84%	159,026 $4.11 Million
Q4 2021 Feb 07, 2022	BUY	$17.46 - $21.61 $447,674 - $554,080	25,640 Added 19.88%	154,631 $3.15 Million
Q3 2021 Nov 02, 2021	BUY	$17.35 - $22.5 $33,815 - $43,852	1,949 Added 1.53%	128,991 $2.48 Million
Q2 2021 Aug 03, 2021	SELL	$18.01 - $28.32 $70,112 - $110,249	-3,893 Reduced 2.97%	127,042 $2.82 Million
Q1 2021 May 04, 2021	BUY	$19.76 - $29.89 $1.61 Million - $2.43 Million	81,450 Added 164.6%	130,935 $3.44 Million
Q4 2020 Feb 01, 2021	SELL	$15.73 - $21.66 $81,025 - $111,570	-5,151 Reduced 9.43%	49,485 $925,000
Q3 2020 Nov 09, 2020	SELL	$13.54 - $26.41 $1.07 Million - $2.09 Million	-79,116 Reduced 59.15%	54,636 $928,000
Q2 2020 Aug 07, 2020	SELL	$7.84 - $23.29 $208,410 - $619,118	-26,583 Reduced 16.58%	133,752 $3.12 Million
Q1 2020 May 04, 2020	SELL	$5.57 - $11.5 $51,917 - $107,191	-9,321 Reduced 5.49%	160,335 $1.35 Million
Q4 2019 Feb 06, 2020	BUY	$7.9 - $10.14 $99,239 - $127,378	12,562 Added 8.0%	169,656 $1.66 Million
Q4 2019 Feb 04, 2020	BUY	$7.9 - $10.14 $119,882 - $153,874	15,175 Added 10.69%	157,094 $1.55 Million
Q3 2019 Nov 12, 2019	BUY	$9.17 - $12.01 $743,641 - $973,950	81,095 Added 133.33%	141,919 $1.35 Million
Q2 2019 Aug 15, 2019	SELL	$10.88 - $17.6 $51,745 - $83,705	-4,756 Reduced 7.25%	60,824 $723,000
Q1 2019 May 03, 2019	SELL	$15.51 - $17.61 $512,667 - $582,080	-33,054 Reduced 33.51%	65,580 $1.16 Million
Q4 2018 Feb 05, 2019	BUY	$14.52 - $19.72 $119,572 - $162,394	8,235 Added 9.11%	98,634 $1.71 Million
Q3 2018 Nov 01, 2018	BUY	$14.85 - $16.35 $525,675 - $578,773	35,399 Added 64.36%	90,399 $1.35 Million
Q2 2018 Aug 02, 2018	BUY	$13.8 - $16.8 $14,973 - $18,228	1,085 Added 2.01%	55,000 $875,000
Q1 2018 May 04, 2018	BUY	$13.8 - $16.2 $292,215 - $343,035	21,175 Added 64.68%	53,915 $766,000
Q4 2017 Feb 01, 2018	BUY	$13.55 - $15.8 $26,923 - $31,394	1,987 Added 6.46%	32,740 $458,000
Q3 2017 Oct 27, 2017	SELL	$13.45 - $14.35 $39,906 - $42,576	-2,967 Reduced 8.8%	30,753 $440,000
Q2 2017 Aug 07, 2017	BUY	N/A	33,720	33,720 $531,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account